MARC details
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128206584 |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC731 |
| Item number |
TAR 2020 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Dua, Kamal |
| Relator term |
editor |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Targeting chronic inflammatory lung diseases using advanced drug delivery systems / |
| Statement of responsibility, etc. |
edited by Kamal Dua, Philip M. Dansbro, Ridhima Wadhwa, Mehra Haghi, Lisa G. Pont and Kylie A. Williams |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Waltham : |
| Name of producer, publisher, distributor, manufacturer |
Elsevier, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2020. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxx, 587 pages : |
| Other physical details |
illustrations |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1. Chronic respiratory diseases: An introduction and need for novel drug delivery approaches 2. Drug delivery of respiratory medicines in practice 3. Advanced drug delivery systems for respiratory diseases 4. Novel drug delivery systems and significance in respiratory diseases 5. Use of biologics in the treatment of asthma, COPD, ACOS, and idiopathic pulmonary fibrosis 6. Targeting biofilms in chronic respiratory infections using drug delivery systems 7. Absorption enhancement of macromolecule administered intrapulmonary 8. In silico analysis of drug delivery in respiratory disease 9. Concepts of nanotechnology in nanomedicine: From discovery to applications 10. Advancement in translational respiratory research using nanotechnology 11. Nanoparticle-based macromolecule drug delivery to lungs 12. Formulation and role of polymeric and inorganic nanoparticles in respiratory diseases 13. Inhalable hybrid nanocarriers for respiratory disorders 14. Functionalized nanoparticles in pulmonary disease diagnosis 15. Drug delivery system in pulmonary disease: Role of microparticles 16. Microparticulate drug delivery systems for targeting respiratory diseases 17. Porous particulate platforms for enhanced pulmonary delivery of bioactives 18. Liposomes in the treatment of chronic respiratory conditions 19. Theranostic drug delivery systems for targeted therapy of lung diseases 20. Targeted polymeric miceller systems for respiratory diseases 21. Hydrogels for pulmonary drug delivery 22. Mucoadhesive drug delivery systems in respiratory diseases 23. Targeting lung cancer using advanced drug delivery systems 24. Plant-based drug delivery systems in respiratory diseases 25. Role of essential oils in respiratory diseases through advanced and nanodrug delivery systems 26. Pharmacokinetics and pharmacodynamics of the advanced drug delivery systems |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Intro -- Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems -- Copyright -- Dedication -- Contents -- Contributors -- Editors biography -- Chapter 1 Chronic respiratory diseases: An introduction and need for novel drug delivery approaches -- 1 Introduction -- 2 Lungs: Morphology and physiology -- 3 Overview of respiratory disease -- 3.1 Asthma -- 3.1.1 Treatments -- 3.2 Chronic obstructive pulmonary disease -- 3.3 Interstitial lung diseases -- 3.4 Cystic fibrosis -- 3.5 Tuberculosis -- 4 Lung cancer -- 4.1.1 Angiogenesis inhibitors -- 4.1.2 Insulin-like growth factor inhibitors -- 4.1.3 Histone deacetylase inhibitors -- 4.1.4 Proapopototic agents -- 5 Challenges of current therapeutic strategies -- 6 Summary and conclusion -- Conflict of interest -- Author contribution -- Funding -- References -- Chapter 2 Drug delivery of respiratory medicines in practice -- 1 Management of inflammatory lung disease in practice -- 1.1 Asthma -- 1.2 COPD -- 2 Drug delivery systems used in the management of chronic inflammatory pulmonary disease -- 3 Inhaler technique and device development -- References -- Chapter 3 Advanced drug delivery systems for respiratory diseases -- 1 Introduction -- 2 Pulmonary drug delivery devices -- 3 Advanced drug delivery systems -- 3.1 Microparticulate and nanoparticulate systems -- 3.2 Phage therapy -- 3.3 Oligonucleotide therapy -- 3.4 Gene delivery -- 4 Conclusion -- References -- Chapter 4 Novel drug delivery systems and significance in respiratory diseases -- 1 Introduction -- 2 Novel pulmonary drug delivery systems-An overview -- 2.1 Mechanisms for pulmonary drug administration -- 2.2 Strategic criteria for particle-based pulmonary delivery systems -- 2.3 General types of pulmonary drug delivery devices -- 3 Novel delivery systems targeting respiratory diseases -- 3.1 Nanoparticles |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Chronic diseases ; Treatment |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Chronic diseases Treatment |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Delivery Systems |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug delivery systems |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Lungs ; Diseases ; Treatment |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Lungs Diseases Treatment |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Dua, Kamal, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Hansbro, Phil, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Haghi, Mehra, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wadhwa, Ridhima, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Pont, Lisa G. |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Williams, Kylie A. |
| Relator term |
editor |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books |
| Classification part |
731 |
| Item part |
TAR |
| Call number prefix |
RC |
